Fosun mulls sale of Indian drug maker Gland valued at US$3.6 billion
A sale of Hyderabad-based Gland, which specialises in injectable drugs such as antibiotics, oncology and cardiology treatments, will help Fosun raise cash and shore up its balance sheet.